Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Cleanroom Supervisor in Meningitis Case Sentenced to Eight Years

By MaryBeth DiDonna | January 31, 2018

Glenn Chin, the supervisory pharmacist said to be involved in a deadly nationwide meningitis outbreak, has been sentenced to eight years in prison, according to the Associated Press.

Jurors in the federal trial found Chin not guilty of second-degree murder on Oct. 25, but convicted him of racketeering and mail fraud charges, and scheduled his sentencing trial for January 2018. The prosecution asked for a 35-year sentence, whereas Chin’s attorneys requested three years.

Read more: Jurors Reach Verdict in Meningitis Trial https://www.cemag.us/blog/2017/10/jurors-reach-verdict-meningitis-trial

Chin supervised the cleanrooms at the New England Compounding Center in Framingham, Mass., which closed in 2012 after a fungal meningitis outbreak caused by tainted steroid injections killed 64 people in nine states and sickened more than 700 others. Chin had faced federal charges of second-degree murder in connection with the deaths of 25 people who were injected with the mold-contaminated steroids. The prosecution accused him of allowing lax cleanroom practices and ignoring unsafe and unprofessional conduct by cleanroom workers.

Read more: Cleanroom QC Agent: Pharmacist Told Me to “[Expletive] Off”: https://www.cemag.us/blog/2017/10/cleanroom-qc-agent-pharmacist-told-me-expletive

According to the Boston Herald, Chin wept as he issued a statement during his sentencing hearing at Boston’s federal courthouse, saying that he’s prayed every day for the victims of the outbreak and that they will “find some sort of peace.”

WCVB reports that Chin’s brother was present in court, but Chin’s wife, Kathy, is not — she is awaiting trial herself, as she was also a NECC employee. A federal appeals court on Jan. 12 wound up reversing a prior decision that had dismissed charges against three NECC pharmacists — Kathy Chin, Michelle Thomas, and Alla Stepanets — who were accused of filling falsified prescriptions. The three had been accused of violating the Federal Food, Drug and Cosmetic Act. The court reversed the prior dismissal and remanded for further proceedings.

Glenn Chin’s conviction came several months after Barry J. Cadden, former co-owner and president of the New England Compounding Center in Framingham, Mass., was acquitted of murder in March 2017. Cadden also faced 25 counts of second-degree murder, but was cleared of these charges after the jury deliberated for five days. Like Chin, Cadden was convicted of racketeering and fraud charges in June 2017, and was sentenced to nine years in prison. Chin plead not guilty to his own charges, and his legal team argued that he was only following Cadden’s orders to “cut corners” during his tenure at the NECC.

Read more: Verdict Reached in Meningitis Case https://www.cemag.us/blog/2017/03/verdict-reached-meningitis-case

Related Articles Read More >

As AI floods drug discovery with designs, Twist uses DNA chips to tackle the wet-lab bottleneck
Interphex 2026 awards honor technologies focused on flexibility, automated workflows and ease of use
What every regulated lab should plan before building a cleanroom
6 essentials for seismic rated cleanrooms
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE